Hegedüs, L.; Okumus, Ö.; Livingstone, E.; Baranyi, M.; Kovács, I.; Döme, B.; Tóvári, J.; Bánkfalvi, Á.; Schadendorf, D.; Aigner, C.;
et al. Allosteric and ATP-Competitive MEK-Inhibition in a Novel Spitzoid Melanoma Model with a RAF- and Phosphorylation-Independent Mutation. Cancers 2021, 13, 829.
https://doi.org/10.3390/cancers13040829
AMA Style
Hegedüs L, Okumus Ö, Livingstone E, Baranyi M, Kovács I, Döme B, Tóvári J, Bánkfalvi Á, Schadendorf D, Aigner C,
et al. Allosteric and ATP-Competitive MEK-Inhibition in a Novel Spitzoid Melanoma Model with a RAF- and Phosphorylation-Independent Mutation. Cancers. 2021; 13(4):829.
https://doi.org/10.3390/cancers13040829
Chicago/Turabian Style
Hegedüs, Luca, Özlem Okumus, Elisabeth Livingstone, Marcell Baranyi, Ildikó Kovács, Balázs Döme, József Tóvári, Ágnes Bánkfalvi, Dirk Schadendorf, Clemens Aigner,
and et al. 2021. "Allosteric and ATP-Competitive MEK-Inhibition in a Novel Spitzoid Melanoma Model with a RAF- and Phosphorylation-Independent Mutation" Cancers 13, no. 4: 829.
https://doi.org/10.3390/cancers13040829
APA Style
Hegedüs, L., Okumus, Ö., Livingstone, E., Baranyi, M., Kovács, I., Döme, B., Tóvári, J., Bánkfalvi, Á., Schadendorf, D., Aigner, C., & Hegedüs, B.
(2021). Allosteric and ATP-Competitive MEK-Inhibition in a Novel Spitzoid Melanoma Model with a RAF- and Phosphorylation-Independent Mutation. Cancers, 13(4), 829.
https://doi.org/10.3390/cancers13040829